ARCHIVES

NCI disclosure of walk-out by Data and Safety Monitoring Board of the National Lung Screening Trial may be harmful, improper, experts say.

This article is from The Cancer Letter archive.

Vol. 30 No. 16 | April 16, 2004

Download PDF Visit The Full Archive

Related Articles

Mayo Clinic Develops New Jaw Reconstruction Method

August 25, 2006

In Brief: New Mount Sinai Cancer Center Gets $7 Million; Jules Harris Named Rush Cancer Center Director

July 25, 1986

Abbott PCR Test For HCV Load Sensitive to Within 12 IU/mL

May 27, 2011

Believers “Flout Fundamental Law Of Physics,” Park Says.

August 1, 2008

NCI Programs: Researchers Take “Director’s Challenge” to Develop Molecular Profiles of Tumors

December 10, 1999

New Genetic Test Approved For Breast Cancer Patients

July 25, 2008